A Study of Orally Administered Pimodivir in Adult Participants With Hepatic Impairment

NCT03816631 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: Pimodivir

Sponsor

Janssen-Cilag International NV